Global Immuno-Oncology Diagnostics Market Research Report 2022: Explosion in Immuno-Oncology Therapies Creates an Exploding Diagnostic Market - Forecast to 2027
March 29, 2022 04:13 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.com's offering....
Proto Oncogene Protein C-MYC Inhibitors Industry 2021 Featuring Insights for 15+ Companies and Drugs, Including RRx-001 (EpicentRx) and WP1066 (Moleculin Biotech)
December 23, 2021 05:28 ET
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Proto Oncogene Protein C-MYC Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...
Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers
December 13, 2021 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered...
Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
November 15, 2021 14:35 ET
|
Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...
Global Market for Immuno-Oncology Diagnostics 2021: Diagnostics Play New Key Role in Therapeutic Development and Clinical Trials
November 01, 2021 05:48 ET
|
Research and Markets
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 - 2026" report has been added to ResearchAndMarkets.com's...
Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors
September 22, 2021 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true...
PD-1 Resistant Head and Neck Cancer (HNC) Market Landscape Report 2021
August 31, 2021 04:08 ET
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
TCR-based Therapies Market Research Report 2021
July 16, 2021 04:58 ET
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
Outlook on the Oncolytic Virus Immunotherapy Global Market to 2026 - Key Drivers and Inhibitors
October 20, 2020 04:08 ET
|
Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026" report has been added to ResearchAndMarkets.com's...
Global Immuno-Oncology Diagnostics Markets 2020-2024: Focus on Biomarkers and the Next Five Years
October 01, 2020 07:29 ET
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "The Race for Biomarkers Market Forecasts for Immuno-Oncology Diagnostics, With Exutive and Consultant Guides and including Customized Forecasting and...